Cargando…
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
Some, but not all, intravenous iron formulations have been recognized to induce renal phosphate wasting syndrome. Most commonly this has been reported following treatment of iron deficiency anemia (IDA) with ferric carboxymaltose (FCM). A search of PubMed identified relevant randomized controlled tr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279965/ https://www.ncbi.nlm.nih.gov/pubmed/34053011 http://dx.doi.org/10.1007/s12325-021-01770-2 |